All IndicationsPhase 3Phase 3Phase 3Phase 2Phase 2
Acromegaly
4
Companies
6
Drug Programs
3
Phase 3
0
Upcoming PDUFAs
Competitors
CRNX
Crinetics Pharmaceuticals, Inc.
Paltusotine
CRNX
Crinetics Pharmaceuticals, Inc.
Placebo
VRTX
Vertex Pharmaceuticals Incorporated
Paltusotine
IONS
Ionis Pharmaceuticals, Inc.
IONIS GHR-LRx
IONS
Ionis Pharmaceuticals, Inc.
IONIS-GHR-LRx
CAMX
Camurus
octreotide
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, Inc. | Paltusotine | Phase 3 | — | — | — |
| CRNX Crinetics Pharmaceuticals, Inc. | Placebo | Phase 3 | — | — | — |
| VRTX Vertex Pharmaceuticals Incorporated | Paltusotine | Phase 3 | — | — | — |
| IONS Ionis Pharmaceuticals, Inc. | IONIS GHR-LRx | Phase 2 | — | — | — |
| IONS Ionis Pharmaceuticals, Inc. | IONIS-GHR-LRx | Phase 2 | — | — | — |
| CAMX Camurus | octreotide | — | — | — | — |
Development Stage Distribution
Unknown
1
Phase 3
3
Phase 2
2
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.